Blue Blood Biotech
CompanyTaiwan
Blue Blood Biotech develops one asset, in phase 2 (BB-101 in diabetic foot ulcer). Mostly protein or enzyme; based in Taiwan.
- 1
- Asset
- Furthest stage
- Phase 2
- 1
- Trial
- 0
- Signals
Pipeline
1Promotes wound healing and tissue repair in diabetic ulcers.
Phase 2, Protein or enzyme, diabetic foot ulcer
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Similar companies4